: vimarsana.com

Special Note Regarding Forward-Looking Statements




Certain statements in this Report contain forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of... | May 13, 2022

Related Keywords

Netherlands , New York , United States , Utah State University , Utah , New Jersey , Argentina , New Brunswick , Ocala , Florida , China , Italy , Syria , Canada , Turkey , Americans , America , Argentine Republic , Syrian , American , Pawel Kalinski , Rintatolimod Ampligen , Roswell Park , Alimentosy Tecnologia , Robertp Edwards , Casper Van Eijck , Hemispherx Biopharma Europe , Monserrato Cagliari , Contract Research Organization , Us Centers For Disease , National Cancer Institute , Contract Manufacturing Organization , Overall Research , Public Library Of Science , Early Access Program , Centre For Human Drug Research , Access Program Early Programs , Roswell Park Comprehensive Cancer Center , Oxford Research Ethics Committee , China Overseas Development Association , European Commission , Buffett Cancer Center , Drug Administration , Amarex Clinical Research , Institute For Viral Research , Armada Healthcare , Shenzhen Smoore Technology , American Association For Cancer Research , International Association World Congress , Netherlands Patent Office , Securities Exchange , Healthcare Regulatory Agency , Access Program , Agency For Healthcare Research , United States Adopted Names Council , University Of Pittsburgh Medical Center , University Of Nebraska Medical Center , University Of Pittsburgh School Medicine , Us National Institutes Of Health , Pharmaceutics International Inc , Cancer Research , Leyden Lab , Cost Recovery Program , Ovarian Cancer Specialized Program Of Research Excellence , Acellories Inc , University Of Pittsburgh , Clinical Research Organization , European Union , Polysciences Inc , Immunotech Inc , Steering Committee , Simmaron Research , Division Of Neurology , Erasmus Medical Center , European Medicines Agency , Covid Scientific Technical Triage Team , Clinical Cancer Research , Research Agreement , Special Note Regarding Forward Looking , Securities Act , Securities Exchange Act , Financial Condition , Annual Report , Severe Acute Respiratory Syndrome , Complete Response Letter , Ampligen New Drug Application , Administracion Nacional De Medicamentos , Tecnologia Medica , Early Access Programs , Pittsburgh Medical , Alferonn Injection , Biological License Application , Chronic Fatigue Syndrome , Evaluate Ampligen , Exploring Ampligen , New Drug Application , Investigational New Drug , Clinical Hold , Pittsburgh Medical Center , Western Equine Encephalitis Virus , Human Drug Research , Final Safety Report , Severe Adverse Events , Complete Response , Review Board , Orphan Drug Product Designation , Medicines Agency , Cost Recovery Authorization , Healthcare Research , Toll Like Receptor , States Adopted Names Council , Expanded Access , Early Access , Special Access Programs , Disease Control , Ovarian Cancer Specialized Program , Research Excellence , Pittsburgh School , Multiple Ampligen , Advanced Recurrent Ovarian Cancer , Clinical Benefit Rate , Objective Response Rates , Triple Negative Breast Cancer , Cancer Metastatic , Cancer Trial , Refractory Melanoma , Pancreatic Cancer , Nebraska Medical Center , Ampligen Orphan Drug Designation , Orphan Drug Designation , Biopharma Europe , Product Designation , Induces Antiviral Activities , Human Pancreatic Cancer Cells , Medical Center , Cancers Special Issue , Innovative Therapies , Systemic Immune Inflammation Index , Lymphocyte Ratio , Chronic Fatigue Immune Dysfunction Syndrome , Patent Cooperation Treaty , Material Transfer , Smoore Technology , State University , Overseas Development Association , Cancer Institute , Viral Research , Utah State , Long Hauler , Sponsor Agreement , Start Up Agreement , Human Challenge Trial , Open Orphan , Research Ethics Committee , Pre Investigational New Drug Applications , Clinical Research , Park Comprehensive Cancer , Orphan Medicinal Products Designation , Cagliari Dipartimento , Patent Application , Contract Manufacturing Organizations , Biologics License Application , Renewed Sales , Supply Agreement , Marketing Authorization , Early Access Approvals , Impatients Agreement , First Commercial Sale , Tech Employees , Trust Agreement , Accounting Pronouncements , Recent Accounting , Accounting Policies , Critical Accounting , Registration Statement , Edgar Online , Aim Immunotech Inc Stock Exchange , News , Information , Press Release , Special , Vote , Egarding , Statements , N , This , Report , Ucontain , Ithin , F , Section , 27a , The , Securities , Fact , End , 1e Aim Us00901b1052 ,